Abstract

An immunophotonics-based novel therapy was developed for the treatment of metastatic cancers. It uses the combination of local laser irradiation and immunological stimulation through administration of immunoadjuvants. This method has shown promising outcomes in pre-clinical and preliminary clinical studies. It can eradicate the treated primary tumors and also can control distant metastases. The clinical results of this novel therapy in treating late-stage, metastatic melanoma and breast cancer patients will be presented. The synergistic phototherapy-induced, adjuvant-enhanced systemic antitumor effect is proposed.

© 2017 Optical Society of America